Avoid Errors With the New HIV Med, Dovato
Dovato (doh-VAH-toh) will be a new complete HIV regimen with TWO meds in one pill...for treatment-naive patients.
It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.
Dovato will try to compete with THREE-med, one-pill combos, such as Biktarvy (bictegravir/emtricitabine/tenofovir).
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals